Apotheek Jans SA
0.9 FTEApotheek Jans reported total assets of €1.18m at the end of the 2025 financial year (annual accounts filed with the NBB on 21 May 2026), with 0.9 full-time equivalent.
The score of Apotheek Jans shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -23 % Total assets +61 % Headcount (avg FTE) -31 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek Jans's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 May 2026
- Year ended 31 Dec 2024filed on 19 May 2025
- Year ended 31 Dec 2023filed on 24 May 2024
- Year ended 31 Dec 2022filed on 01 Sep 2023
- Year ended 31 Dec 2021filed on 10 Jun 2022
Apotheek Jans's financial analysis
- Solvency12.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek Jans
Apotheek Jans's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0429.230.839
- VAT number
- BE0429230839
- Peppol
- Registered · 0208:0429230839 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 27 Jun 1986
- Registered office
- 3770 Riemst
- Size
- Micro · 0.9 FTE
- Latest accounts
- 2025 · filed on 21 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek Jans (SA) has been based in Riemst since 1986, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 27,787 € and equity of 148,615 €; its revenue is not published. With 0.9 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 12.6%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Apotheek Jans
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie du Baty Retail sale of pharmaceutical products Profondeville · balance sheet €1.18m
- Brugafar Retail sale of pharmaceutical products Nieuwpoort · balance sheet €1.18m
- Apotheke Schunck Retail sale of pharmaceutical products Eupen · balance sheet €1.18m
- Medigrex Retail sale of pharmaceutical products Wuustwezel · balance sheet €1.18m
- MPL Pharma Retail sale of pharmaceutical products Ciney · balance sheet €1.05m
- Pharmaphie SDW Retail sale of pharmaceutical products Ghent · balance sheet €1.19m
- Zellik Pharma Retail sale of pharmaceutical products Asse · balance sheet €1.25m
- Sanophar Retail sale of pharmaceutical products Menen · balance sheet €1.17m
Frequently asked questions about Apotheek Jans
What is the revenue of Apotheek Jans?
Apotheek Jans files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek Jans?
In Belgium, the VAT number is the company number prefixed with BE: BE0429230839 for Apotheek Jans, if the company is VAT-registered. Its company number (CBE) is 0429.230.839.
Where is the registered office of Apotheek Jans?
According to the CBE register, the registered office of Apotheek Jans is in 3770 Riemst.
What is the equity of Apotheek Jans?
At the close of the 2025 financial year, the equity of Apotheek Jans amounts to 148,615 €, a solvency of 12.6% of total assets.
How many people work at Apotheek Jans?
0.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Apotheek Jans?
The register lists 5 active mandates at Apotheek Jans. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek Jans
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →